Based on 1 analysts giving stock ratings to CEL-SCI Corp in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+488.24%
CVM Analyst Recommendation Trends
In the current month, CVM has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CVM average Analyst price target in the last month is 10.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
0
0
0
0
0
0
0
0
Buy
1
1
1
1
1
1
1
1
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
1
1
1
1
1
1
1
1
CVM Analyst Rating for Peer Comparison
Updated: Sep 23, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
--
--
--
Actual
-0.68
-0.67
-0.47
Surprise
--
--
--
FAQs
What is CEL-SCI Corp's price target?
Analysts forecast that CEL-SCI Corp's price target is USD 10.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 10.00.
What is the analyst rating for CEL-SCI Corp?
Based on the ratings of CEL-SCI Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.